Cargando…
Elevated cell-free mitochondria DNA level of patients with premature ovarian insufficiency
BACKGROUND: Premature ovarian insufficiency (POI) patients present with a chronic inflammatory state. Cell-free mitochondria DNA (cf-mtDNA) has been explored as a reliable biomarker for estimating the inflammation-related disorders, however, the cf-mtDNA levels in POI patients have never been measur...
Autores principales: | Zhou, Xing-Yu, Yang, Yi-Zhen, Zhang, Jun, Zhang, Xiao-Fei, Liu, Yu-Dong, Wang, Zhe, Chen, Shi-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288775/ https://www.ncbi.nlm.nih.gov/pubmed/37349693 http://dx.doi.org/10.1186/s12884-023-05769-1 |
Ejemplares similares
-
Plasma metabolomic characterization of premature ovarian insufficiency
por: Zhou, Xing-Yu, et al.
Publicado: (2023) -
BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
por: Guo, Xiao, et al.
Publicado: (2023) -
Cell-free fat extract improves ovarian function and fertility in mice with premature ovarian insufficiency
por: Liu, Mengyu, et al.
Publicado: (2022) -
Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency
por: Zhou, Xing-Yu, et al.
Publicado: (2021) -
Premature ovarian insufficiency: Pathogenesis and management
por: Fenton, Anna J.
Publicado: (2015)